FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$7.09Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $331,120,736.00
EPSttm : -3.53
4D Molecular Therapeutics, Inc.
$7.09
3.50%$0.24Float Short %
8.69
Margin Of Safety %
Put/Call OI Ratio
0.05
EPS Next Q Diff
0.09
EPS Last/This Y
-0.71
EPS This/Next Y
-0.11
Price
7.09
Target Price
28.78
Analyst Recom
1.82
Performance Q
96.94
Relative Volume
0.41
Beta
2.79
Ticker: FDMT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | FDMT | 4.56 | 0.04 | 0.00 | 2365 |
| 2025-07-28 | FDMT | 4.64 | 0.04 | 0.00 | 2378 |
| 2025-07-29 | FDMT | 4.36 | 0.03 | 0.00 | 2424 |
| 2025-07-30 | FDMT | 4.41 | 0.03 | 0.02 | 2461 |
| 2025-07-31 | FDMT | 4.5 | 0.03 | 0.00 | 2684 |
| 2025-08-01 | FDMT | 6.4 | 0.03 | 0.11 | 2766 |
| 2025-08-04 | FDMT | 5.22 | 0.10 | 0.35 | 6858 |
| 2025-08-05 | FDMT | 6.05 | 0.13 | 0.09 | 7411 |
| 2025-08-06 | FDMT | 5.72 | 0.13 | 0.08 | 7583 |
| 2025-08-07 | FDMT | 5.78 | 0.14 | 0.35 | 7544 |
| 2025-08-08 | FDMT | 5.62 | 0.13 | 0.00 | 7567 |
| 2025-08-11 | FDMT | 5.52 | 0.13 | 0.24 | 7789 |
| 2025-08-12 | FDMT | 6.16 | 0.13 | 0.06 | 7760 |
| 2025-08-13 | FDMT | 6.67 | 0.13 | 0.02 | 7740 |
| 2025-08-14 | FDMT | 7.1 | 0.13 | 0.02 | 7781 |
| 2025-08-15 | FDMT | 7.26 | 0.13 | 0.01 | 8036 |
| 2025-08-18 | FDMT | 7.28 | 0.05 | 0.01 | 4062 |
| 2025-08-19 | FDMT | 6.57 | 0.06 | 0.02 | 4009 |
| 2025-08-20 | FDMT | 6.85 | 0.05 | 0.00 | 4868 |
| 2025-08-21 | FDMT | 6.85 | 0.05 | 0.00 | 4790 |
| 2025-08-22 | FDMT | 7.1 | 0.05 | 0.01 | 4808 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | FDMT | 4.57 | -9.9 | - | -3.56 |
| 2025-07-28 | FDMT | 4.64 | -9.9 | - | -3.56 |
| 2025-07-29 | FDMT | 4.36 | -9.9 | - | -3.56 |
| 2025-07-30 | FDMT | 4.41 | -9.9 | - | -3.56 |
| 2025-07-31 | FDMT | 4.50 | -9.9 | - | -3.56 |
| 2025-08-01 | FDMT | 6.42 | -9.9 | - | -3.56 |
| 2025-08-04 | FDMT | 5.24 | -9.9 | - | -3.56 |
| 2025-08-05 | FDMT | 6.05 | -9.9 | - | -3.56 |
| 2025-08-06 | FDMT | 5.72 | -9.9 | - | -3.56 |
| 2025-08-07 | FDMT | 5.78 | -9.9 | - | -3.56 |
| 2025-08-08 | FDMT | 5.63 | -9.9 | - | -3.56 |
| 2025-08-11 | FDMT | 5.53 | -10.0 | - | -3.56 |
| 2025-08-12 | FDMT | 6.15 | -10.0 | - | -3.56 |
| 2025-08-13 | FDMT | 6.67 | -10.0 | - | -3.56 |
| 2025-08-14 | FDMT | 7.11 | -10.0 | - | -3.56 |
| 2025-08-15 | FDMT | 7.27 | -10.0 | - | -3.70 |
| 2025-08-18 | FDMT | 7.26 | -10.0 | - | -3.70 |
| 2025-08-19 | FDMT | 6.57 | -10.0 | - | -3.70 |
| 2025-08-20 | FDMT | 6.86 | -10.0 | - | -3.70 |
| 2025-08-21 | FDMT | 6.85 | -10.0 | - | -3.70 |
| 2025-08-22 | FDMT | 7.09 | -24.6 | - | -3.69 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | FDMT | 0.00 | -8.39 | 8.71 |
| 2025-07-28 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-29 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-30 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-31 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-08-01 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-08-04 | FDMT | 0.00 | -7.70 | 8.71 |
| 2025-08-05 | FDMT | 0.00 | -7.70 | 8.71 |
| 2025-08-06 | FDMT | 0.00 | -7.70 | 8.71 |
| 2025-08-07 | FDMT | 0.00 | -7.70 | 8.71 |
| 2025-08-08 | FDMT | 0.00 | -7.70 | 8.71 |
| 2025-08-11 | FDMT | 0.00 | -7.30 | 8.71 |
| 2025-08-12 | FDMT | 0.00 | -7.30 | 8.91 |
| 2025-08-13 | FDMT | 0.00 | -7.30 | 8.91 |
| 2025-08-14 | FDMT | 0.00 | -7.30 | 8.91 |
| 2025-08-15 | FDMT | 0.00 | -7.30 | 8.84 |
| 2025-08-18 | FDMT | 0.00 | -8.81 | 8.69 |
| 2025-08-19 | FDMT | 0.00 | -8.81 | 8.69 |
| 2025-08-20 | FDMT | 0.00 | -8.81 | 8.69 |
| 2025-08-21 | FDMT | 0.00 | -8.81 | 8.69 |
| 2025-08-22 | FDMT | 0.00 | -8.81 | 8.69 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.98
Avg. EPS Est. Current Quarter
-0.98
Avg. EPS Est. Next Quarter
-0.89
Insider Transactions
Institutional Transactions
-8.81
Beta
2.79
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
18
Growth Score
28
Sentiment Score
34
Actual DrawDown %
87.1
Max Drawdown 5-Year %
Target Price
28.78
P/E
Forward P/E
PEG
P/S
11037.28
P/B
0.79
P/Free Cash Flow
EPS
-3.71
Average EPS Est. Cur. Y
-3.69
EPS Next Y. (Est.)
-3.81
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-594375.76
Relative Volume
0.41
Return on Equity vs Sector %
-71.3
Return on Equity vs Industry %
-58.4
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
-0.14
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading